867 — China Medical System Holdings Share News
0.000.00%
Last trade - 00:00- HK$24.82bn
- HK$19.26bn
- CNY8.21bn
Brief: China Medical System Gets Approval Of Drug Clinical Trials For Glucagon Receptor CMS-D005
Brief: China Medical System Says New Drug Application Of Ruxolitinib Phosphate Cream Approved
Brief: China Medical System Says New Drug Application Accepted By NMPA
Brief: China Medical System Declares Interim Dividend Per Share Of RMB0.1507
Brief: China Medical System Holdings Posts H1 Net Income RMB903.4 Mln
Brief: China Medical System Says New Drug Application Approved In China
Brief: China Medical System Completes Dosing Of The First Subject In Phase Iii Bridging Trial
Brief: China Medical System Says New Drug Application Of Lumeblue Approved By NMPA Of China
Brief: China Medical System Says New Drug Application Of Desidustat Tablets Accepted By NMPA Of China
Brief: China Medical System Says New Drug Application Of Ruxolitinib Cream Approved In Macau
Brief: CMS And Incyte Announce Collaboration And License Agreement For Povorcitinib In China And Southeast Asia
Brief: China Medical System Gains Exclusive License For Oral Small-Molecule Jak1 Inhibitor Povorcitinib
Brief: China Medical System Posts Profit For Year Attributable Of RMB2.40 Bln
Brief: China Medical System Announces Approvals Of Drug Clinical Trials
Brief: China Medical System Says Gaining Exclusive License Of Drug Velphoro
Brief: China Medical System Says Approval By Nmpa To Conduct Phase 3 Clinical Trial For Ruxolitinib Cream
Brief: China Medical System Holdings Says New Drug Application Accepted In China
Brief: China Medical System Says HY Profit Up 6.7% To RMB1,916.0 Mln
Brief: China Medical System Gains Exclusive License Of Anti-Ischemic Stroke Class 1 Innovative Drug